Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FCMTV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 80 mg tablets (60-count units). This award, issued on June 3, 2025, with an ultimate completion date of June 4, 2025, represents a single delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The delivery will be fulfilled from the contractor's location in Park Ridge, Illinois, and no set-aside designation was applied to this award.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has established itself as a key supplier within the federal pharmaceutical supply chain, particularly for military healthcare facilities. The company's core operations involve distributing branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare sites nationwide. Xtandi, an oncology treatment, aligns with the contractor's demonstrated portfolio of specialty pharmaceutical products delivered under the DLA SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical support to military medical facilities globally.
Quick answers
Who was awarded contract SPE2DB25FCMTV?
SPE2DB25FCMTV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FCMTV worth?
The government has obligated $4,170 on SPE2DB25FCMTV.
Is contract SPE2DB25FCMTV an order under another contract?
Yes. SPE2DB25FCMTV is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMTV competed?
The extent of competition for SPE2DB25FCMTV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award